The authors present different antidotal strategies in treating phencyclidine (PCP) intoxication based upon specific symptomatic presentation. Evidence exists for dopaminergic, cholinergic and opiate-like activity of PCP in both laboratory and clinical studies. Reviewing these studies, clinical interventions are recommended according to various symptom clusters.
Get full access to this article
View all access options for this article.
References
1.
GianniniA. J. and PriceW. A., Treatment Approaches in Acute PCP Intoxication, Drug Therapy, (in press).
2.
CastellaniS. and AdamsP. M., Effects of Dopaminergic Drugs on Phencyclidine-Induced Behavior in the Rat, Neuropharmacology, 20, pp. 371–374, 1981.
3.
MurrayT. F. and HoritaA., Phencyclidine-Induced Stereotyped Behavior in Rats: Dose-Response Effects and Antagonism by Neuroleptics, Life Sciences, 24, pp. 2217–2225, 1979.
4.
AdamsP. M., Interaction of Phencyclidine with Drugs Affecting Cholinergic Neurotransmission, Neuropharmacology, 19, pp. 151–153, 1980.
5.
CastellaniS. and AdamsP. M., Effects of Dopaminergic and Cholinergic Agents on Phencyclidine Induced Behaviors in Rats, Neurosciences Abstracts, 6, p. 311, 1980.
6.
MenonM. K.ClarkW. G., and VivoniaC., Interaction between Phencyclidine (PCP) and GABA-ergic Drugs: Clinical Implications, Pharmacology, Biochemistry and Behavior, 12, pp. 113–117, 1980.
7.
MeltzerH. Y.SturgeonR. D.SimonovicM., and FessierR. G., Phencyclidine as an Indirect Dopamine Agonist, Psychopharmacological Bulletin, 16, pp. 62–65, 1980.
8.
TongeS. R. and LeonardB. E., Interaction of Phencyclidine with Drugs Affecting Noradrenaline Metabolism in the Rat Brain, Psychopharmacologia, 23, pp. 86–90, 1972.
9.
TaubeH. D.MontelH.HauG., and StarkeK., Phencyclidine and Ketamine: Comparison with the Effect of Cocaine on the Noradrenergic Neurones of the Rat Brain Cortex, Naunyn Schmiedeberg's Archives of Pharmacology, 291, pp. 47–54, 1975.
10.
TongeS. R., Variation in Hydroxytryptamine Metabolism in the Rat: Effects on the Neurochemical Response to Phencyclidine, Journal of Pharmacy and Pharmacology, 23, pp. 711–712, 1971.
11.
SmithR. C.MeltzerH. Y.AroraR. C., and DavisJ. M., Effects of Phencyclidine on [3H]-Catecholamine and [3H]-Serotonin Uptake in Synaptosomal Preparations from Rat Brain, Biochemical Pharmacology, 26, pp. 1435–1439, 1977.
12.
VincentJ. P.KamenkaJ. M.GenesteP., and LazdunskiM., Interaction of Phencyclidines with the Muscarinic and Opiate Receptors in the Central Nervous System, Brain Research, 152, pp. 176–182, 1978.
13.
GianniniA.J.SlabyA. E., and GianniniM. C., Overdose and Detoxification Emergencies, Excerpta Medica/Medical Examination, New Hyde Park, pp. 138–140, 1983.
14.
NagyJ. I.CarterD. A., and FibigerH. C., Anterior Striatal Projections to the Globus Pallidus, Peduncular Nucleus and Substantia Nigra in the Rat, Brain Research, 158, pp. 15–29, 1978.
15.
MurrayT. F. and HoritaA., Dose Response Effects of Phencyclidine on Stereotyped Behavior in Rats, Neurosciences Abstracts, 4, p. 498, 1978.
16.
SchlemmerR. F.JacksonJ. A.PrestonK. L., Phencyclidine Induced Stereotyped Behavior in Monkeys, European Journal of Pharmacology, 52, pp. 379–384, 1978.
17.
BalsterR. L. and ChaitL. D., The Effects of Phencyclidine on Amphetamine Stereotypy in Rats, European Journal of Pharmacology, 48, pp. 445–450, 1978.
18.
FinneganK. T.KannerM. I. and MeltzerH. Y., Phencyclidine-Induced Ipsilateral Rotation in Rats with Nigrostriatal Lesions, Pharmacology, Biochemistry and Behavior, 5, pp. 651–660, 1976.
19.
LuisadaP. V., The Phencyclidine Psychosis: Phenomenology and Treatment, in Phencyclidine (PCP) Abuse: An Appraisal, PetersenR. C. and StillmanR. C. (eds.), NIDA Research Monograph Series, Rockville, Maryland, pp. 241–253, 1978.
20.
CastellaniS.GianniniA. J., and AdamsP.M., Physostigmine and Haloperidol Treatment of Acute Phencyclidine Intoxication, American Journal of Psychiatry, 139, pp. 508–510, 1982.
21.
CastellaniS.GianniniA. J.BoeringaJ. A., Phencyclidine Intoxication: Assessment of Possible Antidotes, Clinical Tox, 19, pp. 313–319, 1982.
22.
GianniniA. J.KalavskyS.GianniniM. C., Possible Role of the DA-2 Receptor in Phencyclidine Psychosis, Neuroscience Abstracts, in press.
23.
GianniniA. J.EighanR.LoiselleR. H., Comparison of Chlorpromazine and Haloperidol in Phencyclidine Psychosis: Role of the DA-2 Receptor, Journal of Clinical Pharmacology, in press.
24.
MaayaniS.WeinsteinH.CohekS., Anticholine-Like Arrangement in Anticholinergic Drugs, Proceedings of the National Academy of Science, 70, pp. 3103–3107, 1973.
25.
WeinsteinH.MaayaniS.SrebrenikS., Psychotomimetic Drugs on Anticholinergic Agents, Molecular Pharmacology, 9, pp. 820–834, 1973.
26.
PasterZ.MaayaniS.WeinsteinH., Cholinolytic Action of Phencyclidine Derivatives, European Journal of Pharmacology, 25, pp. 270–274, 1974.
27.
KloogY.RehaviM.MaayaniS., Anticholinesterase and Antiacetylcholine Activity of 1-Phenylcyclohexylamine Derivatives, European Journal of Pharmacology, 45, pp. 221–227, 1977.
28.
CastellaniS.AdamsP. M., and GianniniA. J., Physostigmine Treatment of Acute Phencyclidine Intoxication, Journal of Clinical Psychology, 43, pp. 10–11, 1982.
29.
GianniniA. J. and CastellaniS., A Case of Phenylcyclohexylpyrrolidine (PHP) Intoxication Treated with Physostigmine, Clinical Toxicology, 19, pp. 505–508, 1982.
30.
SuT. P.ConeE. J.ShannonH., Relative Potencies of Phencyclidine and Analogs in the Opiate-Receptor Binding Assay: Correlation with Relative Potencies in vivo in Mouse and Rat, Research in Community Substance Abuse, 1, pp. 85–98, 1980.
31.
VincentJ. P.KartolvuskiB.GenesteP., Interaction of Phencyclidine (Angel Dust) with a Specific Receptor in Rat Brain Membranes, Proceedings of the National Academy of Science USA, 76, pp. 4678–4682, 1979.
32.
ZukinS. R. and ZukinR. S., Specific 3H-Phencyclidine Binding in Rat Central Nervous System, Proceedings of the National Academy of Science USA, 76, pp. 5372–5376, 1979.
33.
ItzhakY.KalirA.WeismannB. A., Receptor Binding and Antinocioceptive Properties of Phencyclidine Opiate-Like Derivatives, European Journal of Pharmacology, 72, pp. 305–311, 1981.
34.
HoltzmanS. G., Phencyclidine-Like Discrimination Effects of Opioids in the Rat, Journal of Pharmacology and Experimental Therapy, 214, pp. 614–619, 1980.
35.
ShannonH., Evaluation of Phencyclidine Analogs on the Basis of Their Discriminative Stimulus Properties in the Rat, Journal of Pharmacology and Experimental Therapy, 216, pp. 543–551, 1981.
36.
CastellaniS. and GianniniA. J., Effects of Naloxone, Metenkephlin and Morphine on Phencyclidine-Induced Behavior in the Rat, Psychopharmacology, 78, pp. 76–80, 1982.
37.
KometskyC.MarkowitzR. A., and EspositoR. V., Phencyclidine and Naloxone, in PCP (Phencyclidine): Historical and Current Perspectives, DominoE. R. (ed.), NPP Books, Ann Arbor, pp. 321–330, 1981.
38.
MarkowitzR. A. and KornetskyC., Hypersensitivity to Foot-Shock Following Administration with Phencyclidine: Interaction with Naloxone, Federal Proceedings, 37, p. 619, 1978.
39.
VerebeyK.KoganM. J., and MuleS. J., Phencyclidine-Induced Stereotypy in Rats, Psychopharmacology, 75, pp. 44–47, 1981.
